CD8A and Miyoshi myopathy: Additionally, the frequencies of ex vivo detectable SARS-CoV-2-specific CD8+ T cells were significantly reduced in patients with MM compared to the HCs (1.57 × 10−6 vs. 1.43 × 10−5, respectively, p = 0.0096) (Figure 2B).